People with multiple sclerosis appear to have higher rates of thyroid problems than the general population. The link isn’t clear, but shared pathways and MS medication side effects may play a role.

Clinicians frequently reach out to Catherine Varney, DO, asking if it’s safe to prescribe glucagon-like peptide 1 receptor ...

Thyroid blood tests are an important part of diagnosing and treating thyroid disease. Based on how high or low the different values are—including key hormones such as TSH and T4—the lab can determine ...

Veligrotug is an investigational monoclonal antibody that inhibits the activity of insulin-like growth factor-1 receptor.

ICFO has now used the LUCA platform to characterize the thyroid tissue with simultaneous anatomical measurements, the first ...

Viridian Therapeutics advances promising therapies for thyroid eye disease. See why VRDN stock stands to benefit from a growing $4.13B market by 2034.

Adverse pregnancy and neonatal outcomes are increased by maternal thyroid disease and adequate treatment is thought to reduce these risks. Hypothyroidism is commonly treated with levothyroxine ...

Viridian Therapeutics stock popped Monday after the company scored a win in thyroid eye disease, a condition that causes the ...

If you have brittle nails, swollen hands or unusually pale fingertips it may be more than just a damper to your manicure. It ...

A new study conducted at the Huazhong University of Science and Technology (Wuhan, China) found that liver fibrosis is highly ...

THRIVE-2 met all primary and secondary endpoints at the 15-week primary analysis timepoint after 5 infusions of veligrotug.

Viridian Therapeutics said on Monday its experimental drug to treat chronic thyroid eye disease (TED) met the main goal of a late-stage study, sending the company's shares up more than 13% in ...